NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Yiviva

Yiviva

Private
New York City, New YorkHealthcare & Life Scienceshttps://yiviva.com/

Last Round

Series A

Feb 21, 2018

Total Funding Raised

$7M

Company Overview

Yiviva is a biotechnology company that develops multi-target therapeutics from botanical medicines to treat complex, aging-associated diseases, with a focus on cancer and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

botanical medicinemulti-target therapeuticstraditional Chinese medicineherbal medicinecancer therapysystems biologyTCMcombination therapyimmunotherapy enhancementclinical stage biotechdrug discovery platformdrug licensingOrphan Drug Designationinflammatory bowel diseaseIBDliver cancer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yiviva Comps

Public and private peers based on sector, stage, and business model.

Yiviva comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Yiviva Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 21, 2018

Yiviva Investors

Notable investors and investment history

Yiviva investors
InvestorRounds
Asian Fund for Cancer ResearchSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 44% MoM.

  • Nov 10, 2025

    Monthly visitors increased 254% MoM, reaching 3.6K.

Yiviva Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yiviva Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yiviva's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2014
Last FundingFeb 21, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.